Literature DB >> 19421005

The mismatch repair and base excision repair pathways: an opportunity for individualized (personalized) sensitization of cancer therapy.

Sean P Collins1, Anatoly Dritschilo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19421005      PMCID： PMC3552576          DOI： 10.4161/cbt.8.12.8750

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  19 in total

1.  The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability.

Authors:  A Riccio; L A Aaltonen; A K Godwin; A Loukola; A Percesepe; R Salovaara; V Masciullo; M Genuardi; M Paravatou-Petsotas; D E Bassi; B A Ruggeri; A J Klein-Szanto; J R Testa; G Neri; A Bellacosa
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

2.  Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase.

Authors:  F Petronzelli; A Riccio; G D Markham; S H Seeholzer; J Stoerker; M Genuardi; A T Yeung; Y Matsumoto; A Bellacosa
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

3.  Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency.

Authors:  S Bader; M Walker; B Hendrich; A Bird; C Bird; M Hooper; A Wyllie
Journal:  Oncogene       Date:  1999-12-23       Impact factor: 9.867

4.  Differential radiosensitization in DNA mismatch repair-proficient and -deficient human colon cancer xenografts with 5-iodo-2-pyrimidinone-2'-deoxyribose.

Authors:  Yuji Seo; Tao Yan; Jane E Schupp; Valdir Colussi; Kerri L Taylor; Timothy J Kinsella
Journal:  Clin Cancer Res       Date:  2004-11-15       Impact factor: 12.531

5.  Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).

Authors:  R C Urtasun; D Cosmatos; J DelRowe; T J Kinsella; S Lester; T Wasserman; D S Fulton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-09-30       Impact factor: 7.038

6.  MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine.

Authors:  Owen James Sansom; Joanna Zabkiewicz; Stefan Mark Bishop; Jackie Guy; Adrian Bird; Alan Richard Clarke
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

7.  Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.

Authors:  T J Kinsella; J Collins; J Rowland; R Klecker; D Wright; D Katz; S M Steinberg; E Glastein
Journal:  J Clin Oncol       Date:  1988-05       Impact factor: 44.544

Review 8.  Role of DNA mismatch repair defects in the pathogenesis of human cancer.

Authors:  Päivi Peltomäki
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

9.  Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy.

Authors:  Yih Lin Chung; Ae-June Wang; Lin-Fen Yao
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

10.  Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations.

Authors:  S Bader; M Walker; D Harrison
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640
View more
  1 in total

1.  Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.

Authors:  Luís S Santos; Octávia M Gil; Susana N Silva; Bruno C Gomes; Teresa C Ferreira; Edward Limbert; José Rueff
Journal:  Genes (Basel)       Date:  2020-09-17       Impact factor: 4.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.